Analyze the differences and connections between sunitinib and lenvatinib

Sunitinib and Lenvatinib (Lenvatinib) are both targeted therapy drugs and are widely used in the treatment of various malignant tumors. Although they share some similarities in their anti-cancer mechanisms, there are also significant differences.

From the perspective of drug classification, sunitinib is a multi-target tyrosine kinase inhibitor that mainly targets specific tyrosine kinases, including VEGFR, PDGFR and c-KIT. By inhibiting these targets, sunitinib can block tumor angiogenesis, inhibit tumor growth, and thus produce therapeutic effects on a variety of tumors. In terms of indications, sunitinib is commonly used in advanced renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).

Lenvatinib is also a multi-target TKI. Its targets mainly include VEGFR, FGFR, PDGFR, etc., and have similar anti-tumor mechanisms. Lenvatinib is widely used in thyroid cancer, advanced renal cell carcinoma, and certain types of liver cancer. In recent years, studies have shown that lenvatinib exhibits good synergistic effects in combination immunotherapy, providing patients with new treatment options.

In terms of administration method and dosage, sunitinib is usually taken orally at a daily dosage of 50mg, with a 4-week taking and 2-week rest cycle. The standard dose of lenvatinib is 24 mg per day, taken continuously, with no rest period. The dosing regimens of the two are different, reflecting their flexibility and individualized needs in clinical use.

It's worth noting that the side effects of the two drugs also differ. Common side effects of sunitinib include fatigue, high blood pressure, diarrhea and oral mucositis, while lenvatinib may cause high blood pressure, loss of appetite, weight loss and liver function damage. Therefore, when patients use these drugs, they need to be monitored under the guidance of a doctor and the treatment plan should be adjusted in a timely manner.

Reference materials:https://www.sutent.com/